Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata causes hair loss and life quality issues; current treatments are often unsatisfactory, but new drugs like JAK inhibitors show promise.

Chemotherapy may cause recurring hair loss due to an autoimmune response.

After severe COVID-19, 71% of patients experienced excessive hair shedding and thinning within 3 months due to factors like low oxygen levels, medication, stress, and autoimmune disease.

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.

Combining stress management and Minoxidil helps treat stress-related hair loss and improve well-being.

The SARS-CoV-2 vaccine may be linked to triggering autoimmune conditions like Alopecia Areata.

Serum granulysin levels can indicate the activity and prognosis of alopecia areata.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

People with certain skin diseases have higher levels of the hormone prolactin in their blood.

AIRE-deficient rats developed severe autoimmune disease similar to APECED, useful for testing treatments.

New research has found 14 genes linked to the risk of developing alopecia areata, improving understanding and treatment options.

Alopecia areata, a type of hair loss, is likely an autoimmune disease with a genetic link, but its exact cause is still unknown.

Diagnosing alopecia areata is challenging and requires careful examination and various tests to distinguish it from other hair loss types.

A mother and daughter with similar hair loss conditions and identical HLA types suggest a genetic link between the conditions.

A woman with acne and baldness was found to have a rare ovarian condition but successfully had a child through fertility treatment.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

The AIRE gene variant rs2075876 is linked to a higher risk of alopecia areata in males.

Alopecia areata causes hair loss, has no cure, and various treatments exist.

Hair loss can be treated with medications like minoxidil and finasteride or surgery, but treatment effectiveness varies by alopecia type and accurate diagnosis is important.

The article concludes that correctly diagnosing systemic causes of hair loss requires a detailed clinical evaluation and a systematic diagnostic approach.

Alopecia Areata affects people of all ages worldwide, is likely caused by genetic and environmental factors, and can lead to stress and depression, highlighting the need for treatments that address both physical and mental health.

Higher miR-34a levels and the A variant of the MIR-34A gene are linked to increased risk and severity of alopecia areata.

Common types of non-scarring hair loss have various causes and treatments, but more effective solutions are needed.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Diagnosing diffuse alopecia, a hair loss condition, can be challenging and may require a scalp biopsy or tracking the disease's progression when symptoms and skin tests aren't enough.

Telogen effluvium is a hair loss condition with acute cases resolving quickly and chronic cases potentially lasting longer, sometimes requiring treatment.

Immune checkpoint inhibitors can cause skin issues but are linked to better cancer outcomes.

Children's hair loss can be caused by many factors, including autoimmune diseases, emotional stress, genetics, and infections, with treatment and prognosis varying.

Baricitinib improved platelet counts and alopecia in a 16-year-old with chronic immune thrombocytopenia.